Skip to main content

Table 2 Fixed-effects meta-analysis results for clinically relevant delayed bleeding

From: Incidence of delayed bleeding in patients on antiplatelet therapy after mild traumatic brain injury: a systematic review and meta-analysis

Antiplatelet agent subgroup No. of enrolled studies No. of events due to DB (deaths or neurosurgery) No. of patients at risk CRDB mean estimated risk (95% CI)
All 16 5 2930 0.17% (0.06–0.40%)
ASA 11 3 1706 0.18% (0.04–0.51%)
Clopidogrel 9 0 265 0.00% (0.00–1.38%)
DAPT 6 0 175 0.00% (0.00–2.09%)
  1. CRDB = clinically relevant delayed bleeding as defined in the text; 95% CI = 95% confidence interval; All = all patients included in the analysis; ASA = acetylsalicylic acid; DAPT = dual antiplatelet therapy